Although most research and attention focus on adults, children and adolescents suffer from chronic pain and mental health disorders in numbers as high as adults.
A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 medications semaglutide or liraglutide were less likely to ...